Dr. Caron A. Jacobson is the Medical Director, Immune Engineered Cell Therapy Program, Medical Oncology, Dana-Farber Cancer Institute and Assistant Professor, Medicine, Harvard Medical School. Dr. Jacobson specializes in the Use of Chimeric Antigen Receptor T Cell Therapies in Clinical Practice for the treatment of B-cell malignancies. Dr. Jacobson received her medical degree from Columbia University School of Public Health.